nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—TF—Alzheimer's disease	0.552	0.73	CbGaD
Bismuth Subsalicylate—PTGS1—Alzheimer's disease	0.13	0.172	CbGaD
Bismuth Subsalicylate—PTGS2—Alzheimer's disease	0.0742	0.0981	CbGaD
Bismuth Subsalicylate—TF—choroid plexus—Alzheimer's disease	0.0358	0.55	CbGeAlD
Bismuth Subsalicylate—TF—blood vessel—Alzheimer's disease	0.0052	0.0798	CbGeAlD
Bismuth Subsalicylate—Skin papilloma—Rivastigmine—Alzheimer's disease	0.00391	0.0366	CcSEcCtD
Bismuth Subsalicylate—TF—embryo—Alzheimer's disease	0.0031	0.0476	CbGeAlD
Bismuth Subsalicylate—Epigastric pain—Donepezil—Alzheimer's disease	0.00297	0.0278	CcSEcCtD
Bismuth Subsalicylate—Duodenal ulcer—Donepezil—Alzheimer's disease	0.00297	0.0278	CcSEcCtD
Bismuth Subsalicylate—Upset stomach—Galantamine—Alzheimer's disease	0.00282	0.0265	CcSEcCtD
Bismuth Subsalicylate—TF—forebrain—Alzheimer's disease	0.00274	0.0421	CbGeAlD
Bismuth Subsalicylate—Duodenal ulcer—Rivastigmine—Alzheimer's disease	0.00263	0.0247	CcSEcCtD
Bismuth Subsalicylate—TF—telencephalon—Alzheimer's disease	0.00252	0.0387	CbGeAlD
Bismuth Subsalicylate—Gastric ulcer—Donepezil—Alzheimer's disease	0.00247	0.0231	CcSEcCtD
Bismuth Subsalicylate—Venous thrombosis—Memantine—Alzheimer's disease	0.00241	0.0226	CcSEcCtD
Bismuth Subsalicylate—Gastric ulcer—Memantine—Alzheimer's disease	0.00224	0.021	CcSEcCtD
Bismuth Subsalicylate—Gastric ulcer—Rivastigmine—Alzheimer's disease	0.00219	0.0206	CcSEcCtD
Bismuth Subsalicylate—Upset stomach—Donepezil—Alzheimer's disease	0.00219	0.0205	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Rivastigmine—Alzheimer's disease	0.0018	0.0169	CcSEcCtD
Bismuth Subsalicylate—Stinging—Rivastigmine—Alzheimer's disease	0.00157	0.0147	CcSEcCtD
Bismuth Subsalicylate—PTGS1—blood vessel—Alzheimer's disease	0.00154	0.0237	CbGeAlD
Bismuth Subsalicylate—Hearing impaired—Donepezil—Alzheimer's disease	0.00151	0.0141	CcSEcCtD
Bismuth Subsalicylate—TF—nervous system—Alzheimer's disease	0.00149	0.0228	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood vessel—Alzheimer's disease	0.00147	0.0226	CbGeAlD
Bismuth Subsalicylate—TF—central nervous system—Alzheimer's disease	0.00143	0.022	CbGeAlD
Bismuth Subsalicylate—TF—cerebellum—Alzheimer's disease	0.0014	0.0215	CbGeAlD
Bismuth Subsalicylate—Lethargy—Galantamine—Alzheimer's disease	0.00137	0.0129	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Memantine—Alzheimer's disease	0.00137	0.0128	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Donepezil—Alzheimer's disease	0.00131	0.0123	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Donepezil—Alzheimer's disease	0.0013	0.0122	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Memantine—Alzheimer's disease	0.00124	0.0117	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00123	0.0115	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00122	0.0114	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Memantine—Alzheimer's disease	0.00119	0.0112	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Rivastigmine—Alzheimer's disease	0.00116	0.0109	CcSEcCtD
Bismuth Subsalicylate—TF—brain—Alzheimer's disease	0.00114	0.0175	CbGeAlD
Bismuth Subsalicylate—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00111	0.0104	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Memantine—Alzheimer's disease	0.0011	0.0103	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Rivastigmine—Alzheimer's disease	0.00107	0.0101	CcSEcCtD
Bismuth Subsalicylate—Deafness—Memantine—Alzheimer's disease	0.00106	0.00991	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Donepezil—Alzheimer's disease	0.00104	0.0098	CcSEcCtD
Bismuth Subsalicylate—Deafness—Rivastigmine—Alzheimer's disease	0.00103	0.00969	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Galantamine—Alzheimer's disease	0.000976	0.00916	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Memantine—Alzheimer's disease	0.000964	0.00904	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00095	0.00892	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Memantine—Alzheimer's disease	0.000949	0.0089	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Galantamine—Alzheimer's disease	0.000929	0.00871	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000928	0.00871	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Galantamine—Alzheimer's disease	0.000924	0.00867	CcSEcCtD
Bismuth Subsalicylate—Asthma—Donepezil—Alzheimer's disease	0.000899	0.00844	CcSEcCtD
Bismuth Subsalicylate—PTGS2—embryo—Alzheimer's disease	0.000878	0.0135	CbGeAlD
Bismuth Subsalicylate—Tinnitus—Galantamine—Alzheimer's disease	0.000866	0.00812	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000862	0.00809	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000844	0.00792	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Donepezil—Alzheimer's disease	0.000818	0.00768	CcSEcCtD
Bismuth Subsalicylate—Asthma—Memantine—Alzheimer's disease	0.000817	0.00766	CcSEcCtD
Bismuth Subsalicylate—PTGS1—forebrain—Alzheimer's disease	0.000813	0.0125	CbGeAlD
Bismuth Subsalicylate—Dysgeusia—Galantamine—Alzheimer's disease	0.000792	0.00743	CcSEcCtD
Bismuth Subsalicylate—PTGS2—forebrain—Alzheimer's disease	0.000777	0.0119	CbGeAlD
Bismuth Subsalicylate—Epistaxis—Donepezil—Alzheimer's disease	0.000756	0.0071	CcSEcCtD
Bismuth Subsalicylate—PTGS1—telencephalon—Alzheimer's disease	0.000747	0.0115	CbGeAlD
Bismuth Subsalicylate—Weight increased—Memantine—Alzheimer's disease	0.000743	0.00697	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Rivastigmine—Alzheimer's disease	0.000727	0.00682	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Donepezil—Alzheimer's disease	0.00072	0.00675	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Donepezil—Alzheimer's disease	0.000716	0.00672	CcSEcCtD
Bismuth Subsalicylate—PTGS2—telencephalon—Alzheimer's disease	0.000714	0.011	CbGeAlD
Bismuth Subsalicylate—Drowsiness—Rivastigmine—Alzheimer's disease	0.000712	0.00668	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Memantine—Alzheimer's disease	0.000687	0.00644	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Rivastigmine—Alzheimer's disease	0.000672	0.0063	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Donepezil—Alzheimer's disease	0.000671	0.0063	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Galantamine—Alzheimer's disease	0.000665	0.00624	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Memantine—Alzheimer's disease	0.000654	0.00613	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Memantine—Alzheimer's disease	0.00065	0.0061	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Rivastigmine—Alzheimer's disease	0.000639	0.006	CcSEcCtD
Bismuth Subsalicylate—Hallucination—Rivastigmine—Alzheimer's disease	0.000636	0.00597	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Galantamine—Alzheimer's disease	0.000629	0.0059	CcSEcCtD
Bismuth Subsalicylate—Erythema—Donepezil—Alzheimer's disease	0.000627	0.00588	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Memantine—Alzheimer's disease	0.000618	0.0058	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Donepezil—Alzheimer's disease	0.000614	0.00576	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Memantine—Alzheimer's disease	0.000609	0.00572	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000605	0.00567	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Rivastigmine—Alzheimer's disease	0.000596	0.00559	CcSEcCtD
Bismuth Subsalicylate—ALB—brain—Alzheimer's disease	0.000592	0.00909	CbGeAlD
Bismuth Subsalicylate—Somnolence—Galantamine—Alzheimer's disease	0.000587	0.0055	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Galantamine—Alzheimer's disease	0.000581	0.00545	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Galantamine—Alzheimer's disease	0.000574	0.00538	CcSEcCtD
Bismuth Subsalicylate—Constipation—Galantamine—Alzheimer's disease	0.000564	0.00529	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Memantine—Alzheimer's disease	0.000557	0.00523	CcSEcCtD
Bismuth Subsalicylate—Erythema—Rivastigmine—Alzheimer's disease	0.000557	0.00522	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000545	0.00511	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000544	0.0051	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Galantamine—Alzheimer's disease	0.000522	0.00489	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Donepezil—Alzheimer's disease	0.000516	0.00484	CcSEcCtD
Bismuth Subsalicylate—Oedema—Donepezil—Alzheimer's disease	0.000511	0.0048	CcSEcCtD
Bismuth Subsalicylate—Infection—Donepezil—Alzheimer's disease	0.000508	0.00477	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Donepezil—Alzheimer's disease	0.000488	0.00457	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Memantine—Alzheimer's disease	0.000468	0.00439	CcSEcCtD
Bismuth Subsalicylate—Oedema—Memantine—Alzheimer's disease	0.000464	0.00436	CcSEcCtD
Bismuth Subsalicylate—Infection—Memantine—Alzheimer's disease	0.000461	0.00433	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Rivastigmine—Alzheimer's disease	0.000458	0.0043	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Donepezil—Alzheimer's disease	0.000455	0.00427	CcSEcCtD
Bismuth Subsalicylate—Oedema—Rivastigmine—Alzheimer's disease	0.000454	0.00426	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Galantamine—Alzheimer's disease	0.000452	0.00424	CcSEcCtD
Bismuth Subsalicylate—Infection—Rivastigmine—Alzheimer's disease	0.000451	0.00423	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Donepezil—Alzheimer's disease	0.00045	0.00422	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Donepezil—Alzheimer's disease	0.000445	0.00417	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Memantine—Alzheimer's disease	0.000443	0.00415	CcSEcCtD
Bismuth Subsalicylate—PTGS1—nervous system—Alzheimer's disease	0.000441	0.00677	CbGeAlD
Bismuth Subsalicylate—Pain—Donepezil—Alzheimer's disease	0.000437	0.0041	CcSEcCtD
Bismuth Subsalicylate—Constipation—Donepezil—Alzheimer's disease	0.000437	0.0041	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Galantamine—Alzheimer's disease	0.000436	0.00409	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Rivastigmine—Alzheimer's disease	0.000433	0.00406	CcSEcCtD
Bismuth Subsalicylate—PTGS1—central nervous system—Alzheimer's disease	0.000425	0.00652	CbGeAlD
Bismuth Subsalicylate—PTGS2—nervous system—Alzheimer's disease	0.000422	0.00648	CbGeAlD
Bismuth Subsalicylate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000421	0.00395	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Galantamine—Alzheimer's disease	0.00042	0.00394	CcSEcCtD
Bismuth Subsalicylate—Rash—Galantamine—Alzheimer's disease	0.000416	0.0039	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Galantamine—Alzheimer's disease	0.000416	0.0039	CcSEcCtD
Bismuth Subsalicylate—Headache—Galantamine—Alzheimer's disease	0.000413	0.00388	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Memantine—Alzheimer's disease	0.000413	0.00387	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Memantine—Alzheimer's disease	0.000409	0.00383	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Donepezil—Alzheimer's disease	0.000406	0.00381	CcSEcCtD
Bismuth Subsalicylate—PTGS2—central nervous system—Alzheimer's disease	0.000406	0.00623	CbGeAlD
Bismuth Subsalicylate—Body temperature increased—Donepezil—Alzheimer's disease	0.000404	0.00379	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Rivastigmine—Alzheimer's disease	0.000404	0.00379	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Memantine—Alzheimer's disease	0.000404	0.00379	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.0004	0.00375	CcSEcCtD
Bismuth Subsalicylate—Pain—Memantine—Alzheimer's disease	0.000397	0.00373	CcSEcCtD
Bismuth Subsalicylate—Constipation—Memantine—Alzheimer's disease	0.000397	0.00373	CcSEcCtD
Bismuth Subsalicylate—PTGS2—cerebellum—Alzheimer's disease	0.000397	0.00609	CbGeAlD
Bismuth Subsalicylate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000395	0.0037	CcSEcCtD
Bismuth Subsalicylate—Nausea—Galantamine—Alzheimer's disease	0.000392	0.00368	CcSEcCtD
Bismuth Subsalicylate—Pain—Rivastigmine—Alzheimer's disease	0.000388	0.00364	CcSEcCtD
Bismuth Subsalicylate—Constipation—Rivastigmine—Alzheimer's disease	0.000388	0.00364	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Memantine—Alzheimer's disease	0.000383	0.00359	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000374	0.00351	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Memantine—Alzheimer's disease	0.000369	0.00346	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Memantine—Alzheimer's disease	0.000367	0.00344	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Donepezil—Alzheimer's disease	0.000362	0.00339	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Rivastigmine—Alzheimer's disease	0.000361	0.00339	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000359	0.00337	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Donepezil—Alzheimer's disease	0.00035	0.00328	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Donepezil—Alzheimer's disease	0.000338	0.00317	CcSEcCtD
Bismuth Subsalicylate—PTGS1—brain—Alzheimer's disease	0.000337	0.00518	CbGeAlD
Bismuth Subsalicylate—Pruritus—Memantine—Alzheimer's disease	0.000329	0.00308	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Donepezil—Alzheimer's disease	0.000325	0.00305	CcSEcCtD
Bismuth Subsalicylate—Rash—Donepezil—Alzheimer's disease	0.000322	0.00303	CcSEcCtD
Bismuth Subsalicylate—PTGS2—brain—Alzheimer's disease	0.000322	0.00495	CbGeAlD
Bismuth Subsalicylate—Dermatitis—Donepezil—Alzheimer's disease	0.000322	0.00302	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Rivastigmine—Alzheimer's disease	0.000321	0.00302	CcSEcCtD
Bismuth Subsalicylate—Headache—Donepezil—Alzheimer's disease	0.00032	0.00301	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Memantine—Alzheimer's disease	0.000318	0.00298	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000311	0.00292	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Memantine—Alzheimer's disease	0.000307	0.00288	CcSEcCtD
Bismuth Subsalicylate—Nausea—Donepezil—Alzheimer's disease	0.000304	0.00285	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Rivastigmine—Alzheimer's disease	0.0003	0.00282	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Memantine—Alzheimer's disease	0.000295	0.00277	CcSEcCtD
Bismuth Subsalicylate—Rash—Memantine—Alzheimer's disease	0.000293	0.00275	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Memantine—Alzheimer's disease	0.000293	0.00274	CcSEcCtD
Bismuth Subsalicylate—Headache—Memantine—Alzheimer's disease	0.000291	0.00273	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Rivastigmine—Alzheimer's disease	0.000289	0.00271	CcSEcCtD
Bismuth Subsalicylate—Rash—Rivastigmine—Alzheimer's disease	0.000286	0.00269	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000286	0.00268	CcSEcCtD
Bismuth Subsalicylate—Headache—Rivastigmine—Alzheimer's disease	0.000285	0.00267	CcSEcCtD
Bismuth Subsalicylate—Nausea—Memantine—Alzheimer's disease	0.000276	0.00259	CcSEcCtD
Bismuth Subsalicylate—Nausea—Rivastigmine—Alzheimer's disease	0.00027	0.00253	CcSEcCtD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—INS—Alzheimer's disease	5.89e-05	0.000821	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—Alzheimer's disease	5.85e-05	0.000816	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	5.83e-05	0.000813	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—CCL2—Alzheimer's disease	5.79e-05	0.000808	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	5.66e-05	0.000789	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—GAB2—Alzheimer's disease	5.63e-05	0.000785	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL1B—Alzheimer's disease	5.53e-05	0.000771	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—APP—Alzheimer's disease	5.48e-05	0.000765	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	5.43e-05	0.000757	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	5.43e-05	0.000757	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CA4—Alzheimer's disease	5.41e-05	0.000754	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CDK5—Alzheimer's disease	5.29e-05	0.000738	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.29e-05	0.000737	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOD—Alzheimer's disease	5.14e-05	0.000717	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GAPDHS—Alzheimer's disease	5.09e-05	0.000709	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—DHCR24—Alzheimer's disease	5.05e-05	0.000704	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—VEGFA—Alzheimer's disease	5.04e-05	0.000702	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—TNF—Alzheimer's disease	4.96e-05	0.000692	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—TNF—Alzheimer's disease	4.93e-05	0.000688	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ATP5A1—Alzheimer's disease	4.82e-05	0.000672	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GAPDHS—Alzheimer's disease	4.82e-05	0.000672	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	4.72e-05	0.000658	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.71e-05	0.000657	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—Alzheimer's disease	4.62e-05	0.000645	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLD3—Alzheimer's disease	4.6e-05	0.000641	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.6e-05	0.000641	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.55e-05	0.000634	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	4.47e-05	0.000623	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HSD17B10—Alzheimer's disease	4.41e-05	0.000615	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL1B—Alzheimer's disease	4.39e-05	0.000613	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.37e-05	0.00061	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	4.29e-05	0.000599	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA4—Alzheimer's disease	4.29e-05	0.000599	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	4.28e-05	0.000597	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	4.25e-05	0.000592	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP46A1—Alzheimer's disease	4.24e-05	0.000592	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.2e-05	0.000585	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CLU—Alzheimer's disease	4.18e-05	0.000583	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TTR—Alzheimer's disease	4.18e-05	0.000583	CbGpPWpGaD
Bismuth Subsalicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	4.13e-05	0.000576	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ND1—Alzheimer's disease	4.1e-05	0.000572	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—DHCR24—Alzheimer's disease	4.09e-05	0.00057	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	4.04e-05	0.000563	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—VEGFA—Alzheimer's disease	4.01e-05	0.00056	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TNF—Alzheimer's disease	4.01e-05	0.00056	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.01e-05	0.000559	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—Alzheimer's disease	4e-05	0.000558	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—Alzheimer's disease	3.98e-05	0.000555	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	3.94e-05	0.000549	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.94e-05	0.000549	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	3.83e-05	0.000534	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	3.83e-05	0.000534	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Alzheimer's disease	3.82e-05	0.000533	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.81e-05	0.000531	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—Alzheimer's disease	3.81e-05	0.000531	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.79e-05	0.000528	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—A2M—Alzheimer's disease	3.73e-05	0.00052	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—Alzheimer's disease	3.68e-05	0.000514	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.66e-05	0.000511	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLD3—Alzheimer's disease	3.65e-05	0.000509	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.65e-05	0.000509	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.61e-05	0.000503	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—Alzheimer's disease	3.54e-05	0.000493	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	3.51e-05	0.000489	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	3.5e-05	0.000488	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA4—Alzheimer's disease	3.47e-05	0.000484	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.42e-05	0.000477	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	3.4e-05	0.000473	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	3.37e-05	0.00047	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	3.34e-05	0.000465	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	3.31e-05	0.000462	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.3e-05	0.000461	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GAPDHS—Alzheimer's disease	3.27e-05	0.000455	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ND1—Alzheimer's disease	3.25e-05	0.000454	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—Alzheimer's disease	3.24e-05	0.000452	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	3.23e-05	0.00045	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—AKT1—Alzheimer's disease	3.21e-05	0.000448	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—INPP5D—Alzheimer's disease	3.21e-05	0.000447	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	3.19e-05	0.000444	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.18e-05	0.000444	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	3.18e-05	0.000443	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TF—Alzheimer's disease	3.17e-05	0.000442	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.16e-05	0.00044	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	3.12e-05	0.000434	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	3.11e-05	0.000434	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SNCA—Alzheimer's disease	3.11e-05	0.000433	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ATP5A1—Alzheimer's disease	3.1e-05	0.000432	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLD3—Alzheimer's disease	2.95e-05	0.000412	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.95e-05	0.000412	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.92e-05	0.000407	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.91e-05	0.000406	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.91e-05	0.000406	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GAB2—Alzheimer's disease	2.9e-05	0.000404	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.88e-05	0.000401	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HSD17B10—Alzheimer's disease	2.83e-05	0.000395	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APP—Alzheimer's disease	2.83e-05	0.000394	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSENEN—Alzheimer's disease	2.77e-05	0.000386	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.77e-05	0.000386	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	2.75e-05	0.000383	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.74e-05	0.000383	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APH1A—Alzheimer's disease	2.73e-05	0.000381	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP46A1—Alzheimer's disease	2.73e-05	0.00038	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	2.73e-05	0.00038	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.68e-05	0.000374	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NCSTN—Alzheimer's disease	2.66e-05	0.000371	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TPI1—Alzheimer's disease	2.64e-05	0.000368	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CHAT—Alzheimer's disease	2.64e-05	0.000368	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ND1—Alzheimer's disease	2.63e-05	0.000367	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LRP1—Alzheimer's disease	2.59e-05	0.000362	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.57e-05	0.000359	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	2.57e-05	0.000359	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MAOB—Alzheimer's disease	2.53e-05	0.000353	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.51e-05	0.000351	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.51e-05	0.00035	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TPI1—Alzheimer's disease	2.5e-05	0.000349	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.47e-05	0.000345	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GAPDH—Alzheimer's disease	2.44e-05	0.00034	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.41e-05	0.000336	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.39e-05	0.000333	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—A2M—Alzheimer's disease	2.35e-05	0.000328	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EIF2AK2—Alzheimer's disease	2.35e-05	0.000328	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.35e-05	0.000328	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GAPDH—Alzheimer's disease	2.31e-05	0.000322	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SOD1—Alzheimer's disease	2.3e-05	0.000321	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.28e-05	0.000318	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.27e-05	0.000317	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF2—Alzheimer's disease	2.19e-05	0.000305	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PSEN2—Alzheimer's disease	2.16e-05	0.000301	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.12e-05	0.000296	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CST3—Alzheimer's disease	2.11e-05	0.000295	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.1e-05	0.000293	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TPI1—Alzheimer's disease	2.1e-05	0.000292	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CHAT—Alzheimer's disease	2.1e-05	0.000292	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ACHE—Alzheimer's disease	2.05e-05	0.000286	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.03e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—INPP5D—Alzheimer's disease	2.02e-05	0.000282	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MAOB—Alzheimer's disease	2.01e-05	0.00028	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IAPP—Alzheimer's disease	1.98e-05	0.000276	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKCG—Alzheimer's disease	1.97e-05	0.000275	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GAPDH—Alzheimer's disease	1.94e-05	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.92e-05	0.000268	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ENO1—Alzheimer's disease	1.92e-05	0.000268	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.91e-05	0.000267	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.9e-05	0.000264	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.88e-05	0.000262	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—A2M—Alzheimer's disease	1.87e-05	0.000261	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.87e-05	0.000261	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.85e-05	0.000258	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ENO1—Alzheimer's disease	1.82e-05	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.81e-05	0.000252	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.78e-05	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	1.78e-05	0.000248	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GAB2—Alzheimer's disease	1.74e-05	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAU—Alzheimer's disease	1.72e-05	0.000241	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GSK3A—Alzheimer's disease	1.72e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CALM1—Alzheimer's disease	1.71e-05	0.000238	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TPI1—Alzheimer's disease	1.7e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CHAT—Alzheimer's disease	1.7e-05	0.000237	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APP—Alzheimer's disease	1.69e-05	0.000236	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CAV1—Alzheimer's disease	1.68e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.68e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.67e-05	0.000232	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.65e-05	0.00023	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	1.63e-05	0.000228	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.63e-05	0.000228	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MAOB—Alzheimer's disease	1.63e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.63e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.61e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2—Alzheimer's disease	1.6e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—Alzheimer's disease	1.58e-05	0.000221	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.58e-05	0.00022	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GAPDH—Alzheimer's disease	1.57e-05	0.000218	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.55e-05	0.000216	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.53e-05	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.52e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.52e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—A2M—Alzheimer's disease	1.51e-05	0.000211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.49e-05	0.000208	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ADAM10—Alzheimer's disease	1.45e-05	0.000203	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.42e-05	0.000198	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.41e-05	0.000196	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IGF1—Alzheimer's disease	1.4e-05	0.000196	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.4e-05	0.000195	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.35e-05	0.000188	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.34e-05	0.000186	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ACHE—Alzheimer's disease	1.32e-05	0.000183	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—INPP5D—Alzheimer's disease	1.3e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.3e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—LPL—Alzheimer's disease	1.28e-05	0.000179	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—Alzheimer's disease	1.27e-05	0.000178	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO1—Alzheimer's disease	1.23e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS1—Alzheimer's disease	1.23e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—LPL—Alzheimer's disease	1.21e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2D6—Alzheimer's disease	1.21e-05	0.000169	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PRKCG—Alzheimer's disease	1.18e-05	0.000165	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.15e-05	0.000161	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BCHE—Alzheimer's disease	1.15e-05	0.00016	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	1.14e-05	0.000158	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CCR5—Alzheimer's disease	1.12e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.12e-05	0.000156	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.11e-05	0.000155	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—Alzheimer's disease	1.09e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLCB1—Alzheimer's disease	1.08e-05	0.000151	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CALM1—Alzheimer's disease	1.08e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOE—Alzheimer's disease	1.07e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAV1—Alzheimer's disease	1.06e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.06e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ABCA1—Alzheimer's disease	1.05e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CALM1—Alzheimer's disease	1.02e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOE—Alzheimer's disease	1.02e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—LPL—Alzheimer's disease	1.02e-05	0.000142	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CAV1—Alzheimer's disease	1.01e-05	0.000141	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—Alzheimer's disease	9.48e-06	0.000132	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOTCH1—Alzheimer's disease	9.39e-06	0.000131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—Alzheimer's disease	9.35e-06	0.00013	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—Alzheimer's disease	9.18e-06	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—INS—Alzheimer's disease	9.17e-06	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—Alzheimer's disease	9.15e-06	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARGC1A—Alzheimer's disease	9.03e-06	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—Alzheimer's disease	8.99e-06	0.000125	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—GSK3B—Alzheimer's disease	8.81e-06	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CREB1—Alzheimer's disease	8.74e-06	0.000122	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—INS—Alzheimer's disease	8.69e-06	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CALM1—Alzheimer's disease	8.55e-06	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOE—Alzheimer's disease	8.52e-06	0.000119	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAV1—Alzheimer's disease	8.44e-06	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—Alzheimer's disease	8.42e-06	0.000117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—LPL—Alzheimer's disease	8.22e-06	0.000115	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—Alzheimer's disease	8.04e-06	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—Alzheimer's disease	7.62e-06	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—Alzheimer's disease	7.42e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—Alzheimer's disease	7.4e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—Alzheimer's disease	7.35e-06	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—INS—Alzheimer's disease	7.28e-06	0.000102	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—Alzheimer's disease	6.93e-06	9.67e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CALM1—Alzheimer's disease	6.92e-06	9.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOE—Alzheimer's disease	6.89e-06	9.61e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAV1—Alzheimer's disease	6.83e-06	9.52e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—Alzheimer's disease	6.38e-06	8.9e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—Alzheimer's disease	6e-06	8.37e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—INS—Alzheimer's disease	5.89e-06	8.21e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—AKT1—Alzheimer's disease	5.86e-06	8.17e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—Alzheimer's disease	5.16e-06	7.2e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—Alzheimer's disease	5.04e-06	7.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—Alzheimer's disease	4.72e-06	6.59e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—Alzheimer's disease	3.8e-06	5.3e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKT1—Alzheimer's disease	3.7e-06	5.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKT1—Alzheimer's disease	3.5e-06	4.89e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKT1—Alzheimer's disease	2.93e-06	4.09e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKT1—Alzheimer's disease	2.37e-06	3.31e-05	CbGpPWpGaD
